RecruitingNCT07242625
The NDTx-02 app and executive function in children with ADHD or autism
About this title
Read the official source — NCT07242625Device studyAges 5–12South Korea
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 5 years to 12 years. Other eligibility criteria apply.
- Listed locations
- Daegu and 2 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 16, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 48
- Sponsor
- Neudive Inc.
- Sponsor type
- Other organization
- Study type
- Behavioral
- Intervention type
- Behavioural, Device
- Locations
- South Korea
- Age range
- From 5 Years to 12 Years
- Official registry ID
- NCT07242625
- Official title
Show the full official title
A Multi-center, Prospective, Compared, Randomized, Evaluator-blinded, Pilot Study to Evaluate the Effectiveness of Digital Therapeutics 'NDTx-02' on Executive Function in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Daegu · Seoul
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Neudive Inc.
Who can participate?
This study is for people with ADHD. Listed age limits: 5 years to 12 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
